• Appili Therapeutics obtains rights to vaccine for bioterrorism agent

    9 monthes ago - By Healio

    The biopharmaceutical company Appili Therapeutics recently announced that it has signed a license agreement with the National Research Council of Canada to develop a vaccine for Francisella tularensis, a potential bioterrorism agent.
    F. tularensis causes tularemia - a zoonotic disease that humans can contract through tick and deer fly bites, skin contact with infected animals, contaminated water, inhalation of contaminated aerosols or agricultural dusts, and laboratory exposure, according to the CDC. The agency classifies F. tularensis as a Category A pathogen that poses a high risk to
    Read more ...